GPX3 and gastric adenocarcinoma: In stomach adenocarcinoma cells, GPx3 inhibited the level of pyrimidine metabolism via the ROS/AMPK/mTOR signaling pathway, which could affect the migration and invasive ability of these cancer cells and provide ways to reduce their drug resistance [138].